Key result
A combination of low-phosphate diet and sevelamer may reduce cardiac valve calcification in patients with chronic kidney disease.
Why the study?
Does a combination of low-phosphate diet and sevelamer reduce cardiac valve calcification in patients with chronic kidney disease?
Does a combination of low-phosphate diet and sevelamer reduce cardiac valve calcification in patients with chronic kidney disease?
Answers are grounded in this paper and cite their sources.
This editorial highlights emerging evidence that mineral metabolism control (low-phosphate diet and sevelamer) may reduce cardiac valve calcification in CKD patients, though robust controlled trials are needed.
Although less frequent than vascular calcification, cardiac valve calcification (CVC) is a relevant clinical problem affecting about 2%-10% of adults from the general population aged 75 years and older, and is 5- to 10-fold more prevalent in individuals with impaired kidney function. An expanding body of evidence suggests that mineral metabolism abnormalities aside from traditional cardiovascular risk factors are involved in CVC pathogenesis. Nonetheless, very few studies have investigated whether mineral metabolism manipulation impacts CVC. In this issue of the Journal of Nephrology, it is reported that a combination of low-phosphate diet and sevelamer may reduce CVC. Though the observational nature of that study and the lack of a control group significantly limit the generalizability of these results, they fit in with the ongoing debate on the role of chronic kidney disease mineral bone metabolism (CKD-MBD) in the pathogenesis of vascular disease and suggest the importance of mineral metabolism control in patients with CKD.
No takes yet. Share an insight, caveat, or question.
Bellasi et al. (2013) conducted an editorial in Chronic kidney disease and cardiac valve calcification. Low-phosphate diet and sevelamer was evaluated on Cardiac valve calcification. A combination of low-phosphate diet and sevelamer may reduce cardiac valve calcification in patients with chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: